Dr. Wagle is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Avenue
Boston, MA 02215
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2008 - 2012- Brigham and Women's HospitalResidency, Internal Medicine, 2005 - 2008
Harvard Medical SchoolClass of 2005
Certifications & Licensure
MA State Medical License 2008 - 2023
IA State Medical License 1999 - 2018
IL State Medical License 1999 - 2017
NC State Medical License 1998 - 2017
Clinical Trials
- Olaparib + Sapacitabine in BRCA Mutant Breast Cancer Start of enrollment: 2018 Oct 01
- 'ADVANCE' (A Pilot Trial) Start of enrollment: 2019 Mar 21
Publications & Presentations
PubMed
- 661 citationsThe Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic MelanomaEliezer M. Van Allen, Nikhil Wagle, Antje Sucker, Daniel J. Treacy, Cory M. Johannessen
Cancer Discovery. 2014-01-01 - 374 citationsMAP Kinase Pathway Alterations in BRAF-Mutant Melanoma Patients with Acquired Resistance to Combined RAF/MEK InhibitionNikhil Wagle, Eliezer M. Van Allen, Daniel J. Treacy, Dennie T. Frederick, Zachary A. Cooper
Cancer Discovery. 2014-01-01 - 1915 citationsA landscape of driver mutations in melanomaEran Hodis, Ian R. Watson, Gregory V. Kryukov, Stefan T. Arold, Marcin Imielinski
Cell. 2012-07-20
Journal Articles
- Article KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic ResistanceNikhil Wagle, Myles Brown, Rinath Jeselsohn, ScienceDirect
Press Mentions
Breast Cancer: The Diversity of MetastasesNovember 1st, 2024- How a Patient Partnership Is Propelling Cancer ResearchSeptember 14th, 2022
- Dana-Farber’s Dr. Nikhil Wagle Is Using Genomics to Predict a Patient’s Response to Breast Cancer TreatmentJuly 19th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
